DEF 14A: Innoviva, Inc. Announces 2024 Annual Meeting of Stockholders
Proxy Statement
Innoviva, Inc. will hold its 2024 Annual Meeting of Stockholders on June 17, 2024, to elect directors, approve executive compensation, and ratify the selection of independent auditors.
Summary
- Innoviva, Inc. is holding its 2024 Annual Meeting of Stockholders on June 17, 2024, at 11:00 a.m. Eastern Time, at the offices of Willkie Farr & Gallagher LLP in New York.
- Stockholders will vote on the election of six directors, a non-binding advisory resolution on executive compensation, and the ratification of Deloitte & Touche LLP as the company's independent auditors for the fiscal year ending December 31, 2024.
- The Board of Directors recommends voting for all director nominees, for the advisory resolution on executive compensation, and for the ratification of Deloitte & Touche LLP.
- The record date for voting at the Annual Meeting was April 18, 2024, with 62,518,460 shares of Common Stock outstanding.
- Stockholders can vote by proxy via mail, internet, or telephone, or in person at the Annual Meeting.
- D.F. King & Co., Inc. is assisting Innoviva in the solicitation of proxies at an expected cost not exceeding $20,000 plus expenses.
- The company's executive officers include Pavel Raifeld (CEO), Stephen Basso (CFO), and Marianne Zhen (Chief Accounting Officer).
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, which is generally neutral in tone. It provides necessary information for shareholders to make informed decisions. The recommendation to vote 'for' all proposals suggests a positive outlook from the board's perspective.
Positives
- The Board of Directors is recommending a highly qualified, experienced, and diverse slate of director nominees.
- The company provides multiple methods for stockholders to vote, including mail, internet, and telephone.
- The Audit Committee has selected Deloitte & Touche LLP, an independent registered public accounting firm, as the company's independent auditors for the fiscal year ending December 31, 2024.
Risks
- Failure to receive stockholder approval for the proposals could lead to reconsideration of certain decisions by the Board of Directors.
- The presence of forward-looking statements indicates potential risks and uncertainties that could affect actual results.
Future Outlook
The document outlines the agenda and proposals for the upcoming Annual Meeting, indicating the company's focus on corporate governance and shareholder engagement.
Management Comments
- Pavel Raifeld, Chief Executive Officer, invites stockholders to attend the Annual Meeting and encourages them to vote.
- The Board of Directors is recommending a highly qualified, experienced and diverse slate of director nominees for election to the Board of Directors at the Annual Meeting.
Industry Context
This announcement is a standard corporate communication related to the annual meeting of stockholders, a routine event for publicly traded companies.
Comparison to Industry Standards
- The proxy statement adheres to SEC regulations and Nasdaq listing standards, ensuring transparency and compliance.
- The proposals for voting are typical for annual meetings, including director elections, executive compensation, and auditor ratification.
- The disclosure of director compensation and related party transactions aligns with industry best practices for corporate governance.
Related Party Transactions
- The document discloses a strategic partnership with Sarissa Capital Management LP, including investment by Innoviva into an investment fund managed by Sarissa Capital.
- Two of Innoviva's directors are partners of Sarissa Capital, and they recuse themselves from decisions relating to the investment.
- A committee of independent directors is responsible for decisions related to the strategic advisory agreement and investment with Sarissa Capital.
Stakeholder Impact
- Shareholders are provided with information to make informed decisions regarding the election of directors and other important matters.
- The outcome of the votes will influence the company's governance and strategic direction.
- The company's performance and decisions impact employees, customers, and other stakeholders.
Next Steps
- Stockholders are encouraged to vote on the proposals outlined in the Proxy Statement.
- The company will hold the Annual Meeting on June 17, 2024, to conduct the business described in the Proxy Statement.
- The company will file a Form 8-K to report the final voting results after the Annual Meeting.
Key Dates
| Date | Description |
|---|---|
| 2023-12-30 | Deadline for stockholder proposals to be considered for inclusion in next year's proxy materials. |
| 2024-04-18 | Record date for voting at the Annual Meeting. |
| 2024-04-29 | Date of letter to stockholders and mailing of proxy materials. |
| 2024-06-16 | Deadline for voting by internet or phone. |
| 2024-06-17 | Date of the Annual Meeting of Stockholders. |
| 2025-03-19 | Earliest date for submitting a proposal to be presented at the 2025 annual meeting of stockholders but which will not be included in the Company's proxy materials. |
| 2025-04-18 | Latest date for submitting a proposal to be presented at the 2025 annual meeting of stockholders but which will not be included in the Company's proxy materials. Deadline for stockholders who intend to solicit proxies in support of director nominees other than Innoviva nominees to provide notice. |
Keywords
Annual Meeting, Proxy Statement, Stockholders, Directors, Executive Compensation, Deloitte & Touche, Auditors, Voting, Innoviva
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.